Treatment of Alcohol-Related Hepatitis With Arginine
Status:
Withdrawn
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the effectiveness of the amino acid arginine in reducing
liver injury in individuals with alcohol-related hepatitis.
Phase:
Phase 2
Details
Lead Sponsor:
National Center for Complementary and Integrative Health (NCCIH)